Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy
Thomas C. Greenough(Worcester Memorial Hospital), Katherine Luzuriaga(University of Massachusetts Chan Medical School), Piers Barker(Duke Medical Center), Coleen K. Cunningham(Duke Medical Center), Aditya H. Gaur(St. Jude Children's Research Hospital), Terry Fenton(Harvard University), Dennis Panicali(Fox Chase Cancer Center), Margaret McManus(University of Massachusetts Chan Medical School), Petronella Muresan(GTx (United States)), John L. Sullivan, Deborah Persaud(Johns Hopkins University)
Cited by 43
Related Papers
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
|Cell|1991|1.6k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|975
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
|New England Journal of Medicine|2013|581